| MHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signaling TJ Dixon-Salazar, L Fourgeaud, CM Tyler, JR Poole, JJ Park, ... Journal of Neuroscience 34 (35), 11844-11856, 2014 | 63 | 2014 |
| Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer JJ Park, C Hajj, M Reyngold, W Shi, Z Zhang, JJ Cuaron, CH Crane, ... Acta Oncologica 56 (12), 1746-1753, 2017 | 51 | 2017 |
| A new prognostic model in patients with advanced urothelial carcinoma treated with first-line immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, ... European urology oncology 4 (3), 464-472, 2021 | 46 | 2021 |
| PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer VS Koshkin, VG Patel, A Ali, MA Bilen, D Ravindranathan, JJ Park, ... Prostate cancer and prostatic diseases 25 (3), 388-396, 2022 | 22 | 2022 |
| Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes SM Esagian, AR Khaki, LN Diamantopoulos, L Carril‐Ajuria, D Castellano, ... BJU international 128 (2), 196-205, 2021 | 21 | 2021 |
| Interleukin-6 expands homeostatic space for peripheral T cells C Hong, AS Nam, HR Keller, DL Ligons, JY Park, H Yoon, JJ Park, ... Cytokine 64 (2), 532-540, 2013 | 17 | 2013 |
| Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction MM Tetruashvily, JW Melson, JJ Park, X Peng, LM Boulanger Molecular and Cellular Neuroscience 72, 34-45, 2016 | 13 | 2016 |
| Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine M Gigoux, MO Holmström, R Zappasodi, JJ Park, S Pourpe, CC Bozkus, ... Science translational medicine 14 (649), eaba4380, 2022 | 12 | 2022 |
| Association between sites of metastasis and outcomes with immune checkpoint inhibitors in advanced urothelial carcinoma D Makrakis, R Talukder, GI Lin, LN Diamantopoulos, S Dawsey, S Gupta, ... Clinical genitourinary cancer 20 (5), e440-e452, 2022 | 11 | 2022 |
| Association of the time to immune checkpoint inhibitor (ICI) initiation and outcomes with second line ICI in patients with advanced urothelial carcinoma R Talukder, D Makrakis, GI Lin, LN Diamantopoulos, S Dawsey, S Gupta, ... Clinical genitourinary cancer 20 (6), 558-567, 2022 | 6 | 2022 |
| Immunotherapy in metastatic sarcomatoid renal cell carcinoma: A single institution experience JJ Park, O Kellezi, R Hamasha, A Ali, AS Alva Cancer Treatment and Research Communications 25, 100251, 2020 | 6 | 2020 |
| Response and outcomes to immune checkpoint inhibitors in advanced urothelial cancer based on prior intravesical bacillus calmette-guerin R Talukder, D Makrakis, LN Diamantopoulos, L Carril-Ajuria, ... Clinical genitourinary cancer 20 (2), 165-175, 2022 | 4 | 2022 |
| Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer C Hwang, NC Henderson, SC Chu, B Holland, FC Cackowski, A Pilling, ... JAMA Network Open 6 (9), e2334208-e2334208, 2023 | 3 | 2023 |
| Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer D Makrakis, R Talukder, LN Diamantopoulos, L Carril‐Ajuria, ... BJU international 130 (5), 592-603, 2022 | 3 | 2022 |
| The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide S Halabi, S Guo, JJ Park, DM Nanus, DJ George, ES Antonarakis, ... Clinical Cancer Research, OF1-OF8, 2024 | 2 | 2024 |
| Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations JJ Park, A Chu, J Li, A Ali, RR McKay, C Hwang, MK Labriola, A Jang, ... JCO Precision Oncology 8, e2300567, 2024 | | 2024 |
| Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration ZB Zengin, NC Henderson, JJ Park, A Ali, C Nguyen, C Hwang, ... Prostate Cancer and Prostatic Diseases, 1-7, 2024 | | 2024 |
| Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: Patient Selection and Overview of Doublet and Triplet Therapy Data JW Shevach, JJ Park, AJ Armstrong Advances in Oncology, 2024 | | 2024 |
